AQR Capital Management
ATXS

AQR Capital Management’s Astria Therapeutics ATXS Stock Holding History

AQR Capital Management’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12,790
Closed -$95.4K – 2331
2023
Q3 		$95.4K Buy
+12,790
New +$109K ﹤0.01% 2235
2021
Q3 		– Sell
-5,232
Closed -$66K – 2244
2021
Q2 		$66K Sell
5,232
-844
-14% -$11K ﹤0.01% 2203
2021
Q1 		$105K Sell
6,076
-14,064
-70% -$254K ﹤0.01% 2152
2020
Q4 		$259K Buy
+20,140
New +$359K ﹤0.01% 2015

Other funds holding ATXS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.71B AUM 374.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $581M AUM 108.65% 1-Year Est. Return